Introduction
Normal fetal development may offer biologically unique opportunities for efficient gene transfer. However, the fetal milieu is constantly changing because of the exponential growth and development of the fetus and its investing compartments. In addition, normal ontogeny results in a specific temporal pattern of gene expression for proteins and their receptors, which may influence vector tropism or transgene function. Thus, the timing and mode of gene transfer may be critically important in targeting a specific cell or cell population to achieve the desired therapeutic or biological effect. This is particularly true for targeting stem cell populations. Although the statement that 'stem cell populations exist at increased frequency in the fetus' is often used in support of the potential for fetal gene therapy, the accessibility for gene transfer of a specific stem cell compartment may be transient and/or dependant on the mode of vector administration. Thus, an understanding of the accessibility of cell populations to gene transfer during all stages of fetal development by various modes of delivery is critical for the efficacy, safety, and ultimate success of fetal gene therapy.
There have been several modes of gene delivery used in experimental efforts at fetal gene transfer. These include intratracheal, 1-3 intravascular, 4, 5 intraventricular, 6, 7 intracardiac, 8 intraperitoneal, 5,9-12 intraplacental, 13 intramuscular [14] [15] [16] [17] [18] and intra-amniotic injection. 1, 5, [19] [20] [21] [22] Intra-amniotic gene transfer (IAGT) has been used to target organs exposed to amniotic fluid, that is, the skin, amniotic membranes and the respiratory and digestive systems. 12, 14, 19, 23, 24 The skin and the amniotic membranes are directly exposed to the amniotic cavity, whereas the respiratory and digestive systems contact amniotic fluid through fetal breathing 23, 25 and swallowing. 5 Viral vectors, such as adenovirus and retrovirus, have effectively transferred genes after IAGT, with expression, as expected, limited to epithelial surfaces exposed to amniotic fluid. 5, 12, 19, 24 However, in general, gene transfer after intra-amniotic vector injection has been inefficient and transient because of the relatively late developmental stage at which these experiments have been performed. 5, 26, 27 In contrast to previous studies, we have recently reported that early IAGT results in efficient transduction of skin stem cell populations 28 and the ectoderm-derived stem cell populations of the eye, 29 including stem cells in the neuroectoderm-derived retina. However, in the course of these studies we observed a broad range of transduction events involving multiple tissues of all three germ layers. These events were highly dependant upon developmental stage. In this report, we catalog and describe the entire range of tissues transduced at each developmental stage by early IAGT using lentiviral vectors. Our findings confirm that gene expression after IAGT correlates with developmental events, and that early IAGT results in efficient transduction of a surprisingly broad range of cell populations and tissue compartments.
Results

Viability of fetuses following intra-amniotic gene transfer (IAGT)
The fetuses of 95 pregnant BALB/c mice were injected, totaling 696 fetal mice on each gestational day from E8 to E18. These mice are inclusive of the animals reported in our previous two reports of IAGT that focused on ocular and skin stem cell transduction. 28, 29 From E8 to E12, we used an ultrasound-guided injection system to visualize and inject the amniotic space as previously described. 29 After E13, we injected under stereomicroscopic magnification. The overall survival rate was 50.1% (349/696). The survival rates at each gestational day are shown in Figure 1 . Early gestational IAGT was associated with a relatively high mortality compared with late gestational IAGT.
Effect of different vectors and promoters on gene expression after intra-amniotic gene transfer (IAGT)
Early in the course of this study, we tested three types of lentiviral vectors: human immunodeficiency virus-based vectors with either the cytomegalovirus (CMV) or MND promoter, and an equine infectious anemia virus-based vector with CMV promoter. Both CMV and MND promoters are ubiquitously expressing promoters, and in this study we observed no obvious differences in distribution of exogenous gene expression among these three vectors (data not shown). This result suggests that the distribution of the exogenous gene expression is a function of the timing of vector administration rather than selective vector tropism or expression. From the perspective of efficiency of gene expression, we found qualitative differences in expression for specific organs with specific vectors. As the purpose of this study was not to compare efficacy of different types of vectors, but rather to assess maximal distribution of transduction with an efficient vector driven by a ubiquitous promoter, we used the human immunodeficiency virus-based vector with the CMV promoter for most of this study.
Screening for exogenous gene expression after intraamniotic gene transfer (IAGT)
The presence of green fluorescent protein (GFP) expression was screened for in 212 injected mice that survived to the newborn period using fluorescence stereoscopic microscopy. We could detect GFP expression in organs derived from all three germ layers; however, most of the positive organs were derived from ectoderm. Stereomicroscopic images of representative positive organs, other than the skin and eye (which we have described in detail in our previous publications 28, 29 ) are shown in Figure 2 and immunohistologic confirmation in Figure 3 . The immunohistochemistry shown for specific tissues was derived from separate mice killed at similar, or for some tissues, later time points after IAGT to illustrate the longevity of gene expression. Remarkably, GFP expression was observed in tissues derived from mesoderm and neural ectoderm at E8, whereas the expression was limited to only epithelial cells of ectoderm-and endoderm-derived organs after E11. The data at all time points for all organs are summarized in Figure 4 .
Comparison of the relative efficiency of transduction after intra-amniotic gene transfer (IAGT) at different gestational ages
Overall, the number of GFP-positive organs was higher after early gestational IAGT compared with late gestational IAGT ( Figure 5 ). Although some tissues showed GFP expression after IAGT over a range of gestational ages, as a general rule, the efficiency of transduction decreased with increasing gestational age. In these tissues, early gestational IAGT consistently resulted in much higher levels of GFP expression than later gestational IAGT. A typical example would be the expression in skin, which we have described in detail in our previous article that characterized the skin transduction after IAGT. 28 Although the purpose of this study was not quantitative comparison of the efficiency of transduction at different gestational ages for each tissue, there was a clear difference in the amount of GFP expression at early and late gestational IAGT, with greater expression in animals undergoing earlier IAGT, in all of the ectodermal tissues examined.
Developmental window for cell transduction of each tissue
To better understand these data in the context of developmental events, we looked for patterns of gene expression based on the accessibility of cell populations during developmental stages. We could identify nine patterns of tissue gene expression, as shown in Figure 6 . Expression pattern 1 was composed of tissues that showed no expression after IAGT at any gestational age and comprised only mesoderm-and endoderm-derived organs. Pattern 2 consisted of organs transduced by IAGT at E8 but not at later time points. These consisted of neural ectoderm and the specified mesoderm-derived organs. Pattern 3 consisted of organs that expressed GFP primarily after IAGT at E9, but not E8, and included endodermderived organs, such as the thymus and the esophagus. Pattern 4 consisted of organs expressing GFP after IAGT at both E8 and E9 and included surface ectoderm-derived organs, including organs derived from cranial placodes and surface epithelium-derived organs. Pattern 5 consisted of organs that expressed GFP after IAGT from E8 to E10, and consisted of the same surface ectoderm-derived organs as seen in pattern 4, but also included the thyroid. Pattern 6 consisted of organs expressing GFP after IAGT over the longer time span of E8 to E12. This pattern comprised exclusively surface ectoderm-derived organs, such as the skin and the palate. Pattern 7 consisted of tissues with gene expression observed after IAGT over the period from E8 to E16 and included only the cornea. Pattern 8 included tissues expressing GFP throughout the time span of the study, E8-E18, and included specific surface-ectoderm derived populations in the nasal cavity. Pattern 9 was seen only after IAGT at E12 or later and included the lung. These patterns can be better understood in the context of the developmental events described in the 'Discussion' section.
Duration of gene expression after intra-amniotic gene transfer (IAGT) at different gestational ages
The duration of gene expression was also dependant upon the gestational age when IAGT was performed ( Figure 7 ). The animals undergoing IAGT at E8 and E9 
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showed consistent GFP expression in multiple tissues for the duration of this study (more than 18 months for selected animals). In contrast, the number of GFPpositive tissues decreased with aging in animals injected after E10. In fact, we can now say that tissues such as skin, mammary and salivary tissues, muscle, central nervous system and ocular tissues that transduced at E8 and E9 maintained high levels of GFP expression indefinitely. The animals killed at senescence (over 2 years) maintained GFP expression in the same distribution as animals killed at 1 year (data not shown).
Discussion
In this study we document that IAGT can transduce cell populations derived from all three primitive germ layers. The efficiency and distribution of gene transfer are primarily dependant on the developmental stage at the time of vector exposure. Our findings clearly show that early gestational IAGT has a broader organ distribution than that seen later in gestation.
To explain the patterns of gene expression observed in this study, one must consider a number of evolving events. A basic assumption is that IAGT can only Gene expression after IAGT M Endo et al achieve gene transfer to cell populations exposed to the amniotic fluid. However, in each amniotic fluidexposed organ, there may be a developmental window of accessibility for specific cell populations. 30, 31 The corollary is that once their developmental window closes, the same cell populations are no longer accessible. There are three obvious explanations for major changes in stem cell accessibility over time. First, macroscopic changes of embryonic body shape, such as folding and closure, may determine the period of direct contact with the amniotic fluid. [30] [31] [32] [33] [34] [35] Second, differentiation of epithelium, such as formation of the periderm and epithelial stratification in skin, or placode formation and invagination, may obscure access to the expanding stem cell or progenitor cell population. [36] [37] [38] [39] Third, fetal physiological movements, such as breathing and swallowing, help to extend the distribution of amniotic fluid to internal spaces, exposing additional cell populations. 19, 23 The macroscopic changes had a prime importance in determination of the pattern of gene expression during the early stages of this study. There are five major and relevant macroscopic changes: (1) neural tube closure, (2) primitive streak diminishment, (3) breakdown of the buccopharyngeal membrane, (4) invagination of surface and cranial placodes, and (5) closure of the eyelids. At E8 the neural tube remains open, resulting in exposure of the neuronal ectoderm and neural crest cells. This exposure results in gene transfer to the central nervous system, peripheral neural tissues and neural crestderived tissues after IAGT at E8. 31, 40 In addition, at E8, the primitive streak still exists in the caudal region and Figure 4 A comprehensive analysis of the distribution of transduction after intra-amniotic gene transfer (IAGT) at different gestational ages. Whole organ screening for green fluorescent protein (GFP) expression was performed using fluorescent stereomicroscopic analysis after IAGT from E8 to E18. All of the organs listed were screened for GFP fluorescence in the newborn period (P1-P7) in 213 of the injected animals by fluorescence stereomicroscopy. Organs expressing any degree of fluorescence at the time of screening are represented by red bars, and negative organs by black bars.
Gene expression after IAGT M Endo et al gastrulation is still in progress, resulting in exposure of the epiblast cells, representing the nascent mesoderm involved in formation of the skeletal muscle and kidneys. 41 Thus, the distribution of tissues observed in pattern 2 ( Figure 5 ) is explained by the closure of the neural tube and primitive streak between E8 and E9. In addition, between E8 and E9 the buccopharyngeal membrane, which separates the surface ectoderm from the subjacent endoderm, breaks down allowing continuity between the amniotic cavity and the lumen of the foregut. Therefore, in endoderm-derived tissues in communication with foregut, such as thymus, esophagus, tongue and thyroid, the efficiency of GFP expression after IAGT at E8 was less than at E9. This was especially apparent in the thymus and the esophagus, that is, pattern 3. Between E9 and E11, surface and cranial placodes invaginate or bud into the mesenchyme and lose contact with amniotic fluid. The local thickening of the epithelial layer at points around the body represents ectodermal placode formation, or the primordium of hair, teeth and exocrine glands (for example, mammary, salivary and lacrimal glands). The placodes around the cephalic region are cranial placodes and include the lens, otic, hypophyseal, olfactory and trigeminal placodes. The differences in the timing of this invagination or budding event accounts for the differences in the timing of gene transfer to ectodermal-derived organs, such as the differences observed between patterns 4 and 5. Finally, by E16.5-E17, the eyelids invariably close. This closure results in loss of amniotic fluid exposure of the cornea and explains the loss of corneal expression after E16, as shown in pattern 7.
Although macroscopic morphological events explain many of the observations related to gene expression in this study, additional mechanisms, such as epithelial differentiation, must be invoked to explain others. In the skin, the formation of periderm has a major effect on gene transfer. A transitory fetal layer, the periderm, interfaces between the developing epidermis and amniotic fluid. Periderm differentiates in tandem with epidermal development at E10, completely covers the body at E13 37, 38 and is sloughed into amniotic fluid at about E17, as the skin keratinizes. 36 Before the formation of periderm, the skin is a single layer allowing amniotic fluid exposure to the entire nascent skin stem cell population. When expression is visible on the skin after formation of the periderm, it is limited to the periderm and it is lost when the periderm sloughs. 42 At the moment the periderm sloughs, the skin has already changed to multilayered keratinized epidermis, in which there is no potential for direct contact of vector with nonkeratinized cells, especially stem cell populations, which are located in the bulge region of the hair follicle and the basal layer of the epidermis. The same mechanism, stratification, may disturb gene transfer to the other tissues, such as tongue, palate, esophagus and other digestive organs.
A final event that explains the distribution of gene transduction in this study is the onset of fetal respiration and swallowing. Fetal physiological movements, such as respiratory movement and swallowing, help to extend the distribution of the injected vector to the esophagus and tracheobronchial tree. Fetal respiratory movement begins around E15-16, 43 which corresponds to the increase in lung gene expression observed after E14 (pattern 9).
The efficacy of this approach for long-term gene expression is also highly dependent on the transduced cell populations. In general, during early development Figure 5 The frequency of green fluorescent protein (GFP) expression in the organs and tissues screened is dependant upon timing of intra-amniotic gene transfer (IAGT). The data shown in Figure 4 is re-organized into the number of organs expressing GFP derived from each germ layer. The data points represent the average number of organs derived from each germ layer expressing GFP after IAGT at specific gestational ages. The organs screened for each germ layer are listed in Figure 4 (ectoderm ¼ 27 tissues, mesoderm ¼ 6 tissues, endoderm ¼ 9 tissues). A total of 212 mice that underwent IAGT at various gestational ages are: (n ¼ 31(E8); 48(E9); 28(E10); 14(E11); 18(E12); 14(E13); 16(E14); 13(E15); 12(E16); 13(E17); and 5(E18).
Gene expression after IAGT M Endo et al
with rapid exponential growth of fetal tissues, one would anticipate rapid dilution and loss of transduced differentiated cells, even in tissues that have relatively slow cell turnover in the adult. Ongoing high-level expression of a gene in these tissues requires transduction of stem cell or primitive progenitor populations that subsequently give rise to large numbers of transitamplifying cells and subsequent progeny. The fraction of tissue cells ultimately expressing the gene would be a function of the fraction of stem cells transduced, the kinetics of stem cell activation in any particular tissue and the frequency of gene silencing with insertion or subsequent events. This, in turn, may be influenced by the normal participation of the respective stem cell compartment to tissue growth, maintenance and regeneration, as well as the response to tissue injury or other stimuli. Although a detailed assessment of stem cell transduction in all of the tissues described in this study is beyond the scope of this article, we can say that the prolonged expression of transgene in multiple tissues, including many that are known to have rapid cell turnover (that is, skin, cornea and esophageal mucosa), is strongly supportive of stem cell transduction and is difficult to explain by any other mechanism.
In addition, as we have previously shown, 28 there is a significant rate of in vivo gene silencing with the vector construct used in this study, supporting an even higher rate of transduction than is apparent from our Figure 6 The patterns of green fluorescent protein (GFP) expression after intra-amniotic gene transfer (IAGT) at different gestational ages. The expression data shown in Figure 4 is re-arranged according to nine patterns of expression that are related to specific developmental events (see Discussion): Pattern 1-no expression at any time; Pattern 2-expression only after IAGT at E8 but not at later times; Pattern 3-expression primarily after IAGT at E9 without expression at E8; Pattern 4-expression after IAGT at both E8 and E9; Pattern 5-expression after IAGT at E8 through E10; Pattern 6-expression after IAGT from E8 through E12; Pattern 7-expression after IAGT from E8 though E16; Pattern 8-expression after IAGT from E8 through E18; and Pattern 9-expression after IAGT at E12 or later. Figure 7 The duration of gene expression after intra-amniotic gene transfer (IAGT). This figure compares the longevity of the exogenous gene expression after IAGT at different gestational ages. The number of green fluorescent protein (GFP)-positive organs were counted in mice that had undergone IAGT at E8 to E12 at four time intervals: (1) less than 1 week after birth, (2) 1 week to 1month of age, (3) 1 month to less than 1 year after birth and (4) after 1 year of age. The values before 1 week after birth were normalized to 100%. Note that after IAGT at E8 and E9, the expression was maintained in all organs whereas after E10, many organs lost GFP expression.
gene expression analysis. Although we did not analyze gene silencing in detail in this study, it is important to appreciate that it may lead to an underestimation of transduction events or the potential distribution of expression that might be achieved with more optimized vector constructs. A final explanation for the possible loss of expression in later gestational IAGT fetuses is immune response to the GFP protein, but this would likely only apply to expression in the paranasal sinuses and the respiratory tract (patterns 8 and 9). In total, our data strongly support the hypothesis that there are windows of opportunity in early gestation when stem cells are accessible to gene vector. For a given tissue, in the context of the developmental events described above, the earlier in gestation that exposure to vector occurred, the higher the ultimate expression of GFP and the more likely it was that expression would be permanent. Previous reports of fetal gene transfer by intra-amniotic injection have used mid-gestational rodents or sheep. Our results show far more efficient and durable gene expression than any previous intra-amniotic studies. We attribute this difference to the accessibility of stem cell populations in this study and the lack of accessibility by the mid-gestational stage.
The efficiency of transduction and the duration of transgene expression after early IAGT has obvious therapeutic implications. However, there are significant current limitations to any consideration of clinical application of this approach. First, the period during which stem cell transduction occurred (E8-E11) in various tissues corresponds to approximately 21-55 days in human gestation. 38 Although technically IAGT would be feasible, prenatal diagnosis at this stage of pregnancy is not currently possible. However, it is not inconceivable that in the foreseeable future, prenatal diagnostic techniques may improve to the point of diagnosis of genetic abnormalities within this window of opportunity. If that were to happen, there would be a long list of disorders that early gestational IAGT might be applicable toward. However, this study also emphasizes the lack of tissue specificity of this approach. Although some selectivity occurs because of the limited interface between amniotic fluid and fetal tissues, we have documented a surprising number of tissues transduced. This raises obvious concerns about the potential for insertional mutagenesis, developmental effects and the potential for germ line alteration that exists for lentiviral vector-based approaches. These dangers are, if anything, heightened by early gestational transduction. 44 Although, as we have shown for skin, greater tissue specificity and safety can likely be accomplished by the use of tissue-specific promoters or regulated transgene expression, safer gene transfer techniques will need to be developed to alleviate these concerns. From an experimental perspective, however, this model offers the opportunity for proof-of-principle studies to assess the therapeutic potential of gene therapy strategies for a wide range of genetic disorders. In addition, early IAGT offers the potential to positively or negatively influence gene expression in multiple organ systems and stem cell populations with variable degrees of specificity, depending upon the timing of administration and the specific promoters used, suggesting a number of experimental applications for the approach.
Materials and methods
Mice
Balb/c mice were mated in our breeding colony (breeding stock purchased from Jackson Laboratories, Bar Harbor, ME, USA) to achieve accurate time-dated pregnancies. The mice were inspected daily and the day of appearance of the vaginal plug was taken as E0. Pregnant mice from E8 to E18 were used for IAGT. The animals were housed in the laboratory animal facility of the Abramson Pediatric Research Center at The Children's Hospital of Philadelphia, and were maintained in sterilized plastic microisolator cages and given sterilized standard laboratory chow and tap water ad libitum. Litters were housed with the dam until weaning. All experimental protocols were reviewed and approved by The Institutional Animal Care and Use Committee at The Children's Hospital of Philadelphia, and followed guidelines set forth in the National Institutes of Health 'Guide for Care and Use of Laboratory Animals'.
Intra-amniotic vector injection at E8-E12
We used an ultrasound-guided injection system (Vevo 660, VisualSonics, Toronto, Canada) for intra-amniotic vector injection of E8 to E12 pregnant mice. Pregnant mice were anesthetized with isoflurane (3.5% for induction and 2% for maintenance) and placed supine on a platform. The hair on the abdomen was removed using a chemical hair remover (Nair Church & Dwight Co., Inc., Princeton, NJ, USA). The surgical area was disinfected with alcohol and a 1 cm ventral midline incision was made through the skin, abdominal wall and peritoneum. A small segment of the uterus containing one or two fetuses was exteriorized and covered in pre-warmed sterile ultrasound gel (Aquasonic, Parker Laboratories, NJ, USA). The fetuses were scanned using a 40 MHz probe. Pulled and beveled glass microcapillary pipettes (outer diameter ¼ 1.14 mm, inner diameter ¼ 0.53 mm; Humagen, Charlottesville, VA, USA) were backfilled with mineral oil (Sigma, St Louis, MO, USA) and connected to the micropipette holder that is attached to a three-axis microinjector unit. The micropipettes were loaded with vector at the beginning of each procedure. The fetuses were positioned to get clear views of the amniotic space in B-mode. Under two-dimensional visualization, the micropipette tip was physically advanced through the uterine wall and into the amniotic cavity. A set volume of 350 nl of vector suspension was injected with an automated syringe. The micropipette was then physically retracted and a new embryo was positioned and the procedure was repeated. After injections, the fetuses were placed back into the abdominal cavity and one or two new fetuses were pulled out. A total of 6 to 10 fetuses were injected per dam. The overall time of the procedure was limited to 30 min, from incision until closure.
Intra-amniotic vector injection at E13-E18
Under isofluorane anesthesia, the uterus was exposed through a full-depth midline laparotomy and a uterine horn exteriorized. Vector administration was performed by transuterine injection of 5 ml of vector in phosphate buffered saline (PBS) solution using a hand-pulled and beveled glass micropipettes and an automated injection system. The laparotomy was closed in two layers using Gene expression after IAGT M Endo et al interrupted 4-0 vicryl sutures and the mouse was allowed to recover under a radiant warmer.
Immunohistochemistry
The tissue specimens collected for histology and immunohistochemistry were fixed in 10% buffered formalin solution and embedded in paraffin. To evaluate and localize GFP protein in the harvested tissues, 4 mm sections were obtained using a paraffin microtome (Leica RM2035, Instrument GmbH, Germany). The paraffin sections were incubated overnight at 55 1C and then deparaffinized in serial xylene washes, followed by rehydration through a graded alcohol series to deionized water. To quench autofluorescence caused by free aldehydes, slides were placed in sodium borohydoride-PBS (1 mg ml À1 of sodium borohydride, Sigma, in 1% PBS) for 10-20 min. After rinsing in PBS, slides were blocked for specific protein with goat serum (1:10 dilution) for 30 min at room temperature, followed by 30-min incubation with monoclonal rabbit anti-GFP IgG fraction (1:200 dilution; Invitrogen, CA, USA) at 4 1C. The slides were then washed with PBS followed by a peroxidase blocking step with S-2001 (Dako, CA, USA) for 30 min at room temperature. Slides were rinsed with deionized water, then PBS, followed by incubation with biotinylated goat anti-rabbit IgG (1:200 dilution; Vector Lab PK-4001, Burlingame, CA, USA) for 30 min at room temperature. The slides were washed with PBS, and avidin-biotin complex (1:200 dilution; Vector Lab) was added for 30 min at room temperature. The slides were rinsed well in PBS, developed with peroxidase substrate kit (SK-4100; Vector Lab) and lightly stained with Harris hematoxylin, dehydrated in alcohol, cleared in xylene and mounted using Acrymount (Statlab Medical Products, Lewisville, TX, USA).
Lentivirus vectors
Human immunodeficiency virus type 1-based vector. The basic starting materials 45, 46 for generating a self-inactivating human immunodeficiency virus type 1-based vector were kindly provided by I Verma. The modifications of the CS-CG vector included deletion of the remaining right U3 region except for 23 nucleotides downstream of the 3 0 ppt, deletion of the residual envelope and ancillary gag/pol sequences, insertion of the central DNA FLAP, 47 insertion of the Rev response element and insertion of the Woodchuck hepatitis virus post-transcriptional regulatory element, 48 which is modified, eliminating the initiation codon for the Woodchuck hepatitis X protein. The enhanced GFP (Clontech Laboratories, Palo Alto, CA, USA) was located downstream of the human CMV immediate-early promoter or an MND U3 promoter, 49 modified so that all stop codons from the transcription start site to the translation initiation site were removed. The rationale for this modification is theoretical and related to the optimization of translation. 50 The small subunit of the ribosome (40S) is thought to scan upstream of the initiation codon. As the promoter is designed to accept a number of complementary DNA molecules, which may have varying sites for the location of the initiation codon, stop codons, some of which may be in the scanned region and possibly in frame with the AUG, were modified to prevent inadequate translation. Viral vectors, pseudotyped with the vesicular stomatitis virus-G protein envelope, were generated and titered as previously reported. 51 Equine infectious anemia virus-based vector. The starting materials, the packaging plasmid containing the necessary viral genes for generating the vector, pEV53, and the self-inactivating equine infectious anemia virus transfer vector were kindly obtained from B Bunnell, 52, 53 and a plasmid, designated pFL85, containing the full-length equine infectious anemia virus provirus, was obtained from R Stephens. 54 The transfer plasmid was reassembled, retaining the left and right LTRs. The extended packaging signal (from nucleotide position 287-667, using as reference, GenBank accession number AF028232) was inserted after the left LTR, followed by a track of DNA containing the central polypurine tract/central termination sequence (nucleotide position 4812-5008) 55 and the Rev response element (nucleotide position 5400-5531). 54 All Woodchuck hepatitis virus sequences were removed from the provided transfer vector and replaced with the modified Woodchuck hepatitis virus post-transcriptional regulatory element. 48 The GFP was expressed from an internal CMV promoter. Viral vectors, pseudotyped with the vesicular stomatitis virus-G protein envelope, were generated using three plasmid co-transfection in 293T cells, and viral supernatants were concentrated and titered as described above. 51 
Fluorescence macroscopic analysis
We used fluorescent stereomicroscopy (MZ16FA, Leica, Heerburg, Switzerland) for analyzing the GFP expression sites in the vector-injected mice. For these studies, the mice were killed in the newborn period (P1-P7) or at time points later in life, and were immediately dissected to allow direct visualization of the screened organs. To allow comparison of the fluorescence intensity, we maintained the exposure time at 1 s for all photographs.
Statistical analysis
The Excel 2004 (Microsoft, Inc., Redmond, WA, USA) was used to calculate the linear regression and goodness of fit. Where applicable, data points for groups of animals represent the average±s.e.m.
